CURRENT ACADEMIC ROLE & RESPONSIBILITIES
Dr Satish B Rao is an Professor and Head in the Department of Medicine, KMC Mangalore. He teaches MBBS and BDS students. He is also a research guide for post-graduate students.
?
SUBJECTS CURRENTLY TEACHING
| Subject | Semester / Year |
|---|---|
| General Medicine | 5th, 7th and 9th |
ACADEMIC QUALIFICATIONS
| Degree | Specialisation | Institute | Year of passing |
|---|---|---|---|
| MD | General Medicine | KMC Mangalore | 2001 |
| MBBS | KMC Mangalore | 1998 |
Experience
| Institution / Organisation | Designation | Role | Tenure |
|---|---|---|---|
| Department of Medicine, Kasturba Medical College, 沙巴体育 | Professor and Head | 01/10/2023 - till date | |
| KMC, Mangalore | Additional Professor | Teaching | 16/07/2012 - 30/09/2023 |
| KMC, Mangalore | Associate Professor | Teaching | 12/12/2006 to 16/07/2012 |
| KMC, Mangalore | Assistant Professor | Teaching | 12/11/2003 - 11/12/2006 |
| KS Hegde Medical academy | Lecture | Teaching | 12/12/2001 - 11/11/2003 |
Evaluation of a Fixed Dose Combination of drugs in Hypertension and Dyslipidemia.
(Phase III/2006-2007) DCGI REGISTERED
A Randomized, Double-Blind, Placebo-Controlled, parallel group efficacy and safety Study of BI 1356 (5mg, administered orally once daily) over 24 weeks in Type 2 Diabetic Patients with Insufficient Glycemic Control despite Metformin Therapy.
(Phase III/2007-2009) FDA REGISTERED
A Randomized, Double-Blind, Placebo-Controlled, parallel group efficacy and safety study of BI 1356 (5mg, administered orally once daily) over 24 weeks in drug na?ve or previously treated (6 weeks washout) Type -2 Diabetic Patients with Insufficient Glycemic Control.
(Phase III/2007-2009)FDA REGISTERED
A 78 week open label extension to trials assessing the safety and efficacy of BI 1356 (5mg) as monotherapy or in combination with other antidiabetic medication in type 2 diabetic patients.
(Phase III/2008-2011)FDA REGISTERED
Assessment of the Efficacy and tolerability of a fixed – dose combination of Metaprolol and Amlodipine in essential Hypertension.
(Phase III/2008-2009) DCGI REGISTERED
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Infectious disease
Area of Expertise
Infectious disease; HIV
Area of 沙巴体育
Clinical and operational research in Infectious disease; HIV
Professional Affiliations & Contributions
- 沙巴体育 AIDS Society(IAS)
- HIV Medical Association (HIVMA)/IDSA
- 沙巴体育 association of Physicians in AIDS care (IAPAC)
- European society of clinical microbiology and infectious disease (ESCMID)
- 沙巴体育 society of infectious disease
- Life member of AIDS Society Of India
- Member of the API, Mangalore.
CMV retinitis in a HIV patient despite high CD4 count.
Arun S Adhikari P John TR
BMJ 沙巴体育 Asia. 2006 May; 22 (3):214.
Amphotericin B for cryptococcal meningitis in HIV patients: Low dose versus high dose.
Rajeshwari S, Adhikari P, John TR, Pai Meera, Kiran V. Indian J Crit Care Med. 2007 July-September; 11( 3): 112-116.
Invasive candidiasis / candidemia in aquired immunodeficiency syndrome (AIDS ) – a pilot study.
Shetty AJ, Adhikari P, John T R, Kotian M S, Kamath A. Journal of Clinical and Diagnostic 沙巴体育. 2010 February; 3:2149-2150.
Factors affecting adherence to highly active anti-retroviral therapy in HIV positive patients – 沙巴体育ern India.
Akhila JS, Arbind KC, Chandrashekar R Aarathi A, Prabha A. Journal of Clinical and diagnostic research. 2010 August; 4:2875-2877.
Candidaemia in disseminated TB.
Akhila JS, Prabha A, JohnT R, Shashidhar K, Ajee K. Journal of Clinical and diagnostic research. 2010 December; 4: 3465-3467